These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23740728)

  • 1. Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen.
    Jeong BH; Kim SY; Jeon K; Lee SY; Shin SJ; Koh WJ
    J Clin Microbiol; 2013 Aug; 51(8):2747-9. PubMed ID: 23740728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SERODIAGNOSIS OF THE MYCOBACTERIUM AVIUM COMPLEX BY USING IgA ANTIBODIES FOR THE GLYCOPEPTIDOLIPID CORE ANTIGEN].
    Higashi Y; Nakamura S; Tomono H; Ide S; Takazono T; Miyazaki T; Izumikawa K; Yanagihara K; Yamamoto Y; Kohno S
    Kekkaku; 2016 Feb; 91(2):27-32. PubMed ID: 27263221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.
    Kawasaki T; Kitada S; Fukushima K; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Miyazaki A; Nii T; Kuge T; Koba T; Matsuki T; Tsujino K; Miki K; Maekura R; Kida H
    Microbiol Spectr; 2022 Feb; 10(1):e0140621. PubMed ID: 34985326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serodiagnosis of Mycobacterium avium-complex pulmonary disease with an enzyme immunoassay kit that detects anti-glycopeptidolipid core antigen IgA antibodies in patients with rheumatoid arthritis.
    Watanabe M; Banno S; Sasaki K; Naniwa T; Hayami Y; Ueda R
    Mod Rheumatol; 2011 Apr; 21(2):144-9. PubMed ID: 21082209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease.
    Matsuda S; Asakura T; Morimoto K; Suzuki S; Fujiwara K; Furuuchi K; Osawa T; Namkoong H; Ishii M; Kurashima A; Tatsumi K; Ohta K; Hasegawa N; Sasaki Y
    Respir Med; 2020 Sep; 171():106086. PubMed ID: 32917357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of Antibody against Glycopeptidolipid Core as a Marker for Monitoring Treatment Response in Mycobacterium avium Complex Pulmonary Disease: a Prospective Cohort Study.
    Kitada S; Maekura R; Yoshimura K; Miki K; Miki M; Oshitani Y; Nishida K; Sawa N; Mori M; Kobayashi K
    J Clin Microbiol; 2017 Mar; 55(3):884-892. PubMed ID: 28031437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a commercial serodiagnostic kit that measures the serum anti-glycopeptidolipid core IgA antibody in Mycobacterium avium complex pulmonary disease.
    Kitada S
    Respir Investig; 2019 Sep; 57(5):410-414. PubMed ID: 31085120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological assay by use of glycopeptidolipid core antigen for Mycobacterium avium complex.
    Kobashi Y; Mouri K; Obase Y; Kato S; Oka M
    Scand J Infect Dis; 2013 Apr; 45(4):241-9. PubMed ID: 23387370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological diagnosis of
    Tam WO; Wong CF; Wong SSY; Kwan CLY
    J Clin Tuberc Other Mycobact Dis; 2020 Dec; 21():100189. PubMed ID: 32995571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-diagnosis of Mycobacterium avium complex lung disease using serum immunoglobulin A antibody against glycopeptidolipid antigen in Taiwan.
    Shu CC; Ato M; Wang JT; Jou R; Wang JY; Kobayashi K; Lai HC; Yu CJ; Lee LN; Luh KT
    PLoS One; 2013; 8(11):e80473. PubMed ID: 24260398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of anti-glycopeptidolipid-core IgA test for diagnosing Mycobacterium avium complex infection in lung.
    Numata T; Araya J; Yoshii Y; Shimizu K; Hara H; Nakayama K; Kuwano K
    Respirology; 2015 Nov; 20(8):1277-81. PubMed ID: 26338466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin a antibodies to glycopeptidolipid core antigen for
    Kobayashi T; Tsuyuguchi K; Yoshida S; Kurahara Y; Minomo S; Inoue Y; Suzuki K
    Int J Mycobacteriol; 2020; 9(1):76-82. PubMed ID: 32474493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in serological responses to specific glycopeptidolipid-core and common lipid antigens in patients with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium avium complex.
    Fujita Y; Doi T; Maekura R; Ito M; Yano I
    J Med Microbiol; 2006 Feb; 55(Pt 2):189-199. PubMed ID: 16434712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA.
    Kitada S; Levin A; Hiserote M; Harbeck RJ; Czaja CA; Huitt G; Kasperbauer SH; Daley CL
    Eur Respir J; 2013 Aug; 42(2):454-60. PubMed ID: 23100506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary disease in immunocompetent patients.
    Kitada S; Maekura R; Toyoshima N; Naka T; Fujiwara N; Kobayashi M; Yano I; Ito M; Kobayashi K
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):44-51. PubMed ID: 15642983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study.
    Hirose W; Uchiyama T; Nemoto A; Harigai M; Itoh K; Ishizuka T; Matsumoto M; Yamaoka K; Nanki T
    Arthritis Res Ther; 2015 Sep; 17():273. PubMed ID: 26415495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment.
    Fukushima K; Kitada S; Matsumoto Y; Komukai S; Kuge T; Kawasaki T; Matsuki T; Motooka D; Tsujino K; Miki M; Miki K; Nakamura S; Kida H
    Respir Med; 2021 Oct; 187():106585. PubMed ID: 34455309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Serum IgA Antibody Levels against the Glycopeptidolipid Core Antigen during Antibiotic Treatment of Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Park HY; Jeon K; Shin SJ; Koh WJ
    Jpn J Infect Dis; 2017 Sep; 70(5):582-585. PubMed ID: 28367886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis.
    Shibata Y; Horita N; Yamamoto M; Tsukahara T; Nagakura H; Tashiro K; Watanabe H; Nagai K; Nakashima K; Ushio R; Ikeda M; Narita A; Kanai A; Sato T; Kaneko T
    Sci Rep; 2016 Jul; 6():29325. PubMed ID: 27373718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice.
    Iwasaki T; Yamaguchi F; Hayashi M; Kobayashi H; Hirata K; Miyo K; Kondo C; Kanzaki M; Tei K; Abe T; Sakakura S; Inoue D; Yamazaki Y; Tateno H; Yokoe T; Shikama Y
    Ther Adv Respir Dis; 2022; 16():17534666221138002. PubMed ID: 36444981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.